Lori Wirth

32PUBLICATIONS
196CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Dental therapeutics, pharmacology and toxicologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 18, 2026
Anaplastic Thyroid Carcinoma With Kinase Gene Fusions: Report of 3 Cases With Corresponding Cytologic, Histologic, and Molecular Findings.

|Jun 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery.

|Apr 01, 2026
Systemic Treatment of Thyroid Cancer: ASCO Guideline.

Nabil F Saba, Nofisat Ismaila, Douglas Adkins

|Jan 26, 2026
Who Benefits and When? Applying Circulating Tumor Human Papillomavirus DNA for Human Papillomavirus-Associated Oropharyngeal Carcinoma.

Ross D Merkin, Daniel L Faden, Lori J Wirth

|Jan 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.

Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel

Pageof 6

Frequent Collaborators

9 joint publications

Peter M Sadow

5 joint publications

Daniel L Faden

5 joint publications

Ross Merkin

4 joint publications

Jong Chul Park